To validate an AI model or vendor before ABA production use, define the exact workflow, version, data route, users, outputs, human decisions, and downstream actions. Set requirements and failure thresholds first, test representative and adversarial cases against source evidence and a useful baseline, verify vendor terms and security, require independent acceptance, and release only with monitoring, rollback, and stop authority.
Define the production claim
Binh writes one sentence describing what the system will do, for whom, using which inputs, and with what human or automated consequence. He names excluded work. "Helps with authorizations" is too broad; "extracts five defined fields from one payer form for a trained reviewer to confirm before submission" is testable. The vendor, model alias, configuration, prompt, retrieval corpus, integration, and user interface form one evaluated system.
Set acceptance rules before testing
The acceptance plan names each requirement, test population, expected evidence, metric, threshold, critical failure, reviewer, and disposition. It includes accuracy and completeness, abstention, source citation, wrong-client isolation, access control, latency, availability, accessibility, audit logs, correction, export, deletion, and change notice. NIST SP 800-218A informs AI development, integration, and acquisition controls within its scope. Any clinical, coding, privacy, security, payer, financial, employment, or legal decision stays with the qualified role that owns it.
Compare against a useful baseline
NIST TEVV emphasizes evaluation in context and meaningful data. Compare the AI workflow with the current human or simpler automated process on the same locked cases when feasible. Measure first-pass output and the work needed to detect and repair errors. A model that improves a narrow extraction score may still worsen total review time or make severe errors harder to notice.
Test the real operating range
Include ordinary cases, rare formats, missing pages, ambiguous text, conflicting sources, scanned records, low-quality images, multiple languages, access needs, new payer rules, prompt injection, wrong-client content, long inputs, timeouts, vendor unavailability, and model change. The NIST Generative AI Profile identifies risks such as confabulation and misleading citations that need use-case testing. Keep invalid test setup separate from system failure. Retain every planned case, result, reviewer correction, exclusion, and unresolved defect in the denominator.
Verify vendor and data boundaries
HHS determines business-associate status by function and PHI activity. Its cloud guidance says a cloud service provider maintaining ePHI is a business associate even if it cannot view encrypted data, and each regulated party retains duties for its role. The FTC staff article warns AI companies to honor privacy and confidentiality commitments, including promises about model training. Confirm current terms, subprocessors, regions, retention, training and secondary use, deletion, incident notice, export, model changes, and end-of-contract return.
Separate vendor diligence from workflow acceptance
A vendor can satisfy contractual and security diligence while a proposed workflow still fails its accuracy, accessibility, authority, or human-review gates. The reverse can also occur when a useful prototype depends on unresolved vendor terms. Record both decisions, their owners, evidence dates, conditions, and expiry. Production requires every applicable gate to clear for the same version and data route.
Use staged release
Binh starts with fictional data, then a controlled retrospective set under approved access, then shadow mode where the output cannot change work, then limited production with mandatory review. Each stage has a stop rule and promotion evidence. Production access remains narrow, and logs connect input, version, output, reviewer, edits, final action, and downstream result. A pilot success does not authorize later use cases or silent vendor features.
Work through a locked evaluation
Binh locks 120 fictional and authorized retrospective cases for a payer-form extraction workflow. The system meets all critical requirements in 96 cases: 96 of 120, or 80%. Twelve cases contain unsupported values, four miss a required field, three attach a citation to the wrong page, two mix member records, and three time out without a visible hold. The wrong-member cases are release blockers even though the overall percentage looks high.
Make the release decision explicit
Record approved scope, versions, thresholds, known limitations, prohibited uses, reviewers, residual risks, monitoring, rollback, revalidation triggers, and expiry. A conditional release names the exact interim control and due date. A failed release remains failed until targeted remediation and a locked retest pass. Vendor marketing, a BAA, a security report, or a benchmark score cannot substitute for this workflow-specific acceptance.
Use a concise diligence checklist
- Can we reproduce the vendor's claim on our cases?
- Which severe errors are hidden by the average?
- Does the reviewer see enough source evidence to correct the output?
- What data reaches the vendor and its subprocessors?
- Can we export, delete, pause, and roll back?
- Which change forces revalidation?
Test the correction workload and fallback
A useful evaluation measures the entire operating task, including review, correction, escalation, and recovery. Binh records how long reviewers spend locating the source, understanding the output, correcting it, and reconciling downstream fields. He separately records errors that a reviewer misses, because fast approval can reflect automation bias rather than efficiency. Cases that abstain, time out, or arrive without usable evidence stay in the denominator and exercise the approved manual fallback.
The fallback is tested under realistic volume and deadline pressure. Staff should know where held work appears, who owns it, how to prevent duplicate submission, and how to continue essential services during a vendor outage. If the fallback cannot handle the expected queue, the production claim must be narrowed or the release delayed. A model is not operationally ready merely because its successful outputs look accurate.
Write a decision memo another reviewer can challenge
The final memo should identify the evaluated system, locked cohort, baseline, planned thresholds, results by severity and stratum, unresolved defects, vendor and data findings, accessibility findings, required human role, prohibited uses, monitoring plan, stop rules, and expiration date. Link every conclusion to retained evidence. A dissenting reviewer should be able to state which result or assumption they dispute and what additional test would resolve it.
Conditional approval needs a narrow scope and a real endpoint. For example, Binh may allow one payer form, trained reviewers, and shadow comparison for 30 days while a source-display defect is repaired. The condition specifies the accountable owner, daily signal, maximum volume, rollback route, and automatic end date. Expansion requires a new recorded decision rather than the absence of an incident.
Verify the production handoff
Before access opens, confirm that user roles match the approved cohort, training covers known limitations, the interface exposes required evidence, and monitoring can distinguish the released version. Run one end-to-end fictional case through intake, AI processing, review, correction, downstream action, audit log, and rollback. The operating owner signs that the manual fallback, support route, and stop contact are usable during the hours the workflow will run.
Schedule the first production review before launch. It should examine raw outputs, reviewer edits, severe errors, abstentions, unavailable cases, accessibility concerns, unexpected uses, vendor changes, and downstream reconciliation. If the evidence cannot be collected, production monitoring is already broken. A short controlled delay is preferable to releasing a system whose safety and performance claims cannot be checked.
Related resources
- Defend ABA AI Workflows Against Prompt Injection and Unsafe Tool Use
- Build an ABA AI Use-Case Inventory and Risk-Tiering System
- Validate Retrieval-Augmented Generation and Citations for ABA Work
- Respond to AI Errors, Data Exposure, and Unsafe Actions in ABA Practices
Sources
- Council of Autism Service Providers, Organizational Guidelines public overview
- National Institute of Standards and Technology, AI Risk Management Framework
- National Institute of Standards and Technology, AI RMF Playbook
- National Institute of Standards and Technology, Generative AI Profile
- National Institute of Standards and Technology, SP 800-218A Secure Software Development Practices for Generative AI
- National Institute of Standards and Technology, AI Test, Evaluation, Validation and Verification
- U.S. Department of Health and Human Services, Business Associates
- U.S. Department of Health and Human Services, Guidance on HIPAA and Cloud Computing
- Federal Trade Commission, AI Companies: Uphold Your Privacy and Confidentiality Commitments